DYNC1I1
Cytoplasmic dynein 1 intermediate chain 1
Also known as: DC1I1_HUMAN, DNCI1, DNCIC1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14576
- Gene
- DYNC1I1
- Ensembl
- ENSG00000158560
- Chromosome
- 7
- Canonical length
- 645 aa
- Protein class
- Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables spectrin binding activity. Involved in vesicle transport along microtubule. Located in several cellular components, including kinetochore; recycling endosome; and spindle pole. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
645 residues, UniProt reviewed canonical sequence.
>O14576|DYNC1I1
1 MSDKSDLKAE LERKKQRLAQ IREEKKRKEE ERKKKEADMQ QKKEPVQDDS DLDRKRRETE
61 ALLQSIGISP EPPLVQPLHF LTWDTCYFHY LVPTPMSPSS KSVSTPSEAG SQDSGDLGPL
121 TRTLQWDTDP SVLQLQSDSE LGRRLHKLGV SKVTQVDFLP REVVSYSKET QTPLATHQSE
181 EDEEDEEMVE SKVGQDSELE NQDKKQEVKE APPRELTEEE KQQILHSEEF LIFFDRTIRV
241 IERALAEDSD IFFDYSGREL EEKDGDVQAG ANLSFNRQFY DEHWSKHRVV TCMDWSLQYP
301 ELMVASYNNN EDAPHEPDGV ALVWNMKFKK TTPEYVFHCQ SSVMSVCFAR FHPNLVVGGT
361 YSGQIVLWDN RSHRRTPVQR TPLSAAAHTH PVYCVNVVGT QNAHNLITVS TDGKMCSWSL
421 DMLSTPQESM ELVYNKSKPV AVTGMAFPTG DVNNFVVGSE EGTVYTACRH GSKAGIGEVF
481 EGHQGPVTGI NCHMAVGPID FSHLFVTSSF DWTVKLWTTK HNKPLYSFED NADYVYDVMW
541 SPVHPALFAC VDGMGRLDLW NLNNDTEVPT ASVAIEGASA LNRVRWAQAG KEVAVGDSEG
601 RIWVYDVGEL AVPHNDEWTR FARTLVEIRA NRADSEEEGT VELSALocalizationUniProt · AlphaFold · HPA
Whether an antibody against DYNC1I1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 61 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 61 nTPM
- cerebral cortex: 55 nTPM
- midbrain: 42 nTPM
- hypothalamus: 41 nTPM
- spinal cord: 39 nTPM
- hippocampal formation: 33 nTPM
Single-cell type
- choroid plexus epithelial cells: 863 nCPM
- corticotrophs: 861 nCPM
- müller glia: 705 nCPM
- adrenal medulla cells: 702 nCPM
- podocytes: 687 nCPM
- lactotrophs: 654 nCPM
Immune cell
- neutrophil: 1.4 nTPM
- plasmacytoid DC: 0.8 nTPM
- NK-cell: 0.6 nTPM
- basophil: 0.5 nTPM
- classical monocyte: 0.3 nTPM
- gdT-cell: 0.3 nTPM
Brain region
- pons: 184 nTPM
- cerebral cortex: 179 nTPM
- midbrain: 160 nTPM
- cerebellum: 144 nTPM
- hypothalamus: 144 nTPM
- hippocampal formation: 132 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.21
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- cytoskeletal motor activity
- dynein heavy chain binding
- dynein light chain binding
- microtubule binding
- microtubule motor activity
- spectrin binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DYNC1I1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DYNC1I1 as an antibody target. Whether an autoantibody or antibody against DYNC1I1 could matter depends on whether native DYNC1I1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DYNC1I1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DYNC1I1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...